Literature DB >> 4057533

Left ventricular responses to supine bicycle exercise assessed by radionuclide angiocardiography and a Swan-Ganz catheter.

A Yoshida, K Kadota, H Kambara, S Tamaki, Y Suzuki, C Kawai, N Tamaki, K Torizuka.   

Abstract

Left ventricular responses to supine bicycle ergometer exercise were studied by gated radionuclide angiocardiography (RNA), in 12 normal subjects (group A), 11 coronary patients without effort angina (group B) and 17 coronary patients with effort angina (group C). In the serial measurement of global ejection fraction (EF) there was a significant increase during peak exercise (PEx) in group A and B. In group C, global EF during mild exercise (MEx) did not increase, but decreased significantly during PEx. These results suggest the necessity of achieving adequate exercise loading in the diagnosis of exercise-induced ischemia, and also, that the serial measurement of global EF during exercise appears to be highly valuable. In the assessment of regional wall motion on the basis of regional EF, abnormal responses to exercise were highly inducible in the anteroseptal region in coronary patients with left anterior descending artery involvement. Abnormal wall motion in the other regions was less indicative for right coronary or left circumflex artery dysfunction. We examined hemodynamic responses to exercise by a Swan-Ganz catheter during RNA study in 5 patients of group A, 5 of group B, and 9 of group C. There was a large increase in left ventricular stroke work index (LVSWI) with a small rise in pulmonary capillary wedge pressure (PCWP) in group A. In group B LVSWI increased with a moderate rise in PCWP during PEx. In group C there was a negligible increase of LVSWI despite a marked rise in PCWP. A similar relationship was present between the LVSWI and the end-diastolic count (EDC) in the left ventricular region of interest. In MEx, however, the rise in PCWP in group C was more prominent than the increase in EDC. Thus, the present data indicate that the left ventricle in group C operates on a steeper portion of the diastolic pressure-volume curve than that in group A or B.

Entities:  

Mesh:

Year:  1985        PMID: 4057533     DOI: 10.1253/jcj.49.661

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  6 in total

1.  Noninvasive prediction of the exercise-induced elevation in left ventricular filling pressure in post-heart transplant patients with normal left ventricular ejection fraction.

Authors:  Jaroslav Meluzin; Petr Hude; Jan Krejci; Lenka Spinarova; Helena Podrouzkova; Pavel Leinveber; Ladislav Dusek; Vladimir Soska; Josef Tomandl; Petr Nemec
Journal:  Exp Clin Cardiol       Date:  2013

2.  Physiological hypertrophy of the heart and atrial natriuretic peptide during rest and exercise.

Authors:  J Svanegaard; K Angelo-Nielsen; J S Hansen
Journal:  Br Heart J       Date:  1989-12

3.  Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Rick A Nishimura; Paul Sorajja; Carolyn S P Lam; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2010-06-11       Impact factor: 8.790

Review 4.  The Evolving Landscape of Exercise-Induced Pulmonary Hypertension.

Authors:  J Sawalla Guseh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-06

5.  Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure.

Authors:  Jan M Griffin; Barry A Borlaug; Jan Komtebedde; Sheldon E Litwin; Sanjiv J Shah; David M Kaye; Elke Hoendermis; Gerd Hasenfuß; Finn Gustafsson; Emil Wolsk; Nir Uriel; Daniel Burkhoff
Journal:  J Am Heart Assoc       Date:  2020-08-15       Impact factor: 5.501

Review 6.  Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review.

Authors:  Katarina Zeder; Chiara Banfi; Gregor Steinrisser-Allex; Bradley A Maron; Marc Humbert; Gregory D Lewis; Andrea Berghold; Horst Olschewski; Gabor Kovacs
Journal:  Eur Respir J       Date:  2022-10-13       Impact factor: 33.795

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.